| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |